David Otaegui
Impact in
- Cancer Research top 1%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Clinical Biochemistry top 2%
- Metabolism and Genetic Disorders
Papers in
-
- MicroRNA in disease regulation 25
- Cancer-related molecular mechanisms research 10
-
- Multiple Sclerosis Research Studies 18
- Co-authors
- Leire IparraguirreMaider Muñoz‐CullaAdolfo López de MunaínCharles H. LawrieLorea ManterolaTamara Castillo‐TriviñoAinhoa AlberroEsther Arnaiz
- Journals
- Multiple Sclerosis Journal (6 papers)PLoS ONE (5 papers)International Journal of Molecular Sciences (4 papers)Scientific Reports (3 papers)Human Molecular Genetics (3 papers)
- Partner nations
- SpainUnited StatesUnited Kingdom
In The Last Decade
David Otaegui
81 papers receiving 3.0k citations
Peers
Comparison fields: 5 of 126
- Cancer Research 1.2k
- Clinical Biochemistry 221
- Molecular Biology 2.1k
- Neurology 192
- Pathology and Forensic Medicine 365
Countries citing papers authored by David Otaegui
This map shows the geographic impact of David Otaegui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Otaegui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Otaegui more than expected).
Fields of papers citing papers by David Otaegui
This network shows the impact of papers produced by David Otaegui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Otaegui. The network helps show where David Otaegui may publish in the future.
Co-authors
The 25 scholars most cited alongside David Otaegui, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 5 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 23 | |
| 5 | 2024 | 3 | |
| 6 | 2023 | 4 | |
| 7 | 2021 | 15 | |
| 8 | 2021 | 117 | |
| 9 | 2020 | 9 | |
| 10 | 2020 | 65 | |
| 11 | 2020 | 25 | |
| 12 | 2018 | 317 | |
| 13 | 2013 | 16 | |
| 14 | 2009 | 8 | |
| 15 | 2008 | 28 | |
| 16 | 2008 | 5 | |
| 17 | 2007 | 19 | |
| 18 | 2006 | 26 | |
| 19 | 2006 | 38 | |
| 20 | 2004 | 36 |
About David Otaegui
David Otaegui is a scholar working on Cancer Research, Pathology and Forensic Medicine, Neurology, Molecular Biology and Geriatrics and Gerontology, having authored 86 papers that have together received 3.1k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (25 papers), Multiple Sclerosis Research Studies (18 papers), Circular RNAs in diseases (15 papers), Extracellular vesicles in disease (11 papers), Cancer-related molecular mechanisms research (10 papers), Mitochondrial Function and Pathology (8 papers), RNA regulation and disease (8 papers) and Parkinson's Disease Mechanisms and Treatments (5 papers). The work is most often cited by research in Cancer Research (1.2k citations), Clinical Biochemistry (221 citations), Molecular Biology (2.1k citations), Neurology (192 citations) and Pathology and Forensic Medicine (365 citations). David Otaegui has collaborated with scholars based in Spain, United States and United Kingdom. Frequent co-authors include Leire Iparraguirre, Maider Muñoz‐Culla, Adolfo López de Munaín, Charles H. Lawrie, Lorea Manterola, Tamara Castillo‐Triviño, Ainhoa Alberro, Esther Arnaiz, Iñaki Osorio-Querejeta and Carla Solé. Their work appears in journals such as Multiple Sclerosis Journal, PLoS ONE, International Journal of Molecular Sciences, Scientific Reports and Human Molecular Genetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.